Researchers disrupt molecule that causes excess mucus in lungs, may prompt new treatments for pulmonary disease
Scientists have reversed the damage caused by asthma in mice by targeting specific molecules that cause an overproduction of mucus in the lungs and airways. They hope this leads to new drugs to better treat asthma, COPD, cystic fibrosis and perhaps COVID-19.
Excess mucus in the lungs can be fatal for asthma patients, but scientists at the University of Colorado Anschutz Medical Campus have broken up those secretions at the molecular level and reversed their often deadly effects.
In a study published Monday in the journal Nature Communications, the researchers explained how they created an inhaled treatment that disrupted the production of excess mucus by reducing disulfide bonds in mice and opening up their airways. The same treatment had similar impacts on human mucus samples.
“Currently about 10% of the population has asthma,” said the study’s lead author Christopher Evans, PhD, professor of Pulmonary Sciences & Critical Care at the CU School of Medicine. “Excessive mucus blocks airflow, causing wheezing, and worsening the effects of inflammation and contraction of the muscles that line the airways.”
Yet treatments for asthma like bronchodilators and steroids are rarely effective against mucus. Evans said they hydrate the mucus making it easier to cough up, but fail to treat the problem at the molecular level.
He and his team targeted macromolecules in mucus called polymeric mucin glycoproteins. They help protect the lungs and airways from infection in healthy individuals. But when overproduced, they can make gelatinous plugs that block airways as seen in asthma and other pulmonary conditions.
The researchers tried to shut down this process by breaking up mucin disulfide bonds which contribute to the overproduction of mucus. They treated asthmatic mice with a chemical known as TCEP (tris(2-carboxyethyl)phosphine) which quickly reversed the disease. It also worked on human mucus taken as samples from asthma patients.
“We showed that disrupting mucin disulfide bonds loosens the mucus and reverses the pathological effects of mucus hypersecretion in a mouse allergic asthma model,” said study co-author Ana Maria Jaramillo, PhD, a postdoctoral fellow at CU Anschutz. “Loosening the mucus reduces airway inflammation, enhances mucociliary clearance and abolishes airway hyperactivity.”
The researchers said that while TCEP would likely irritate human lungs, something similar could be added to drugs treating asthma, COPD, cystic fibrosis and other pulmonary diseases making them much more effective at reducing mucus.
“You can develop safer mucolytic compounds using this kind of strategy,” Evans said. “They could help steroids and albuterol penetrate deeper into the lungs and airways. They could be used as an adjunct therapy.”
Such new compounds might also be used in treating pulmonary fibrosis and even infections like pneumonia or Covid-19 which attacks the lungs and airways.
“These findings establish grounds for developing treatments to inhibit effects of mucus hypersecretion in asthma,” Evans said. “I believe they have life-saving potential.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Global Asthma Market is set to grow at Double Digit CAGR During 2021–2027 – MRSon August 4, 2021 at 4:33 am
The Asthma research provides a thorough and all-encompassing view of the global industry. The comprehensive research report includes essential data, as well as the market size and share of the global ...
- Asthma and COPD Drug Market Companies Profiles 2021, Size, Share, Growth, SWOT Analysis, Trends and Forecast by 2027 with Top Growth Companieson August 3, 2021 at 10:36 pm
In 2021, “ Asthma and COPD Drug Market “ Size, Status and Market Insights, Forecast to 2027 |( Number of Pages:121) ...
- HRT could raise odds for asthmaon August 3, 2021 at 12:41 pm
Millions of women who take hormone replacement therapy (HRT) to ease their transition through menopause may be unknowingly upping their risk for asthma.
- US Asthma & COPD Market with Progressing CAGR in Forecast Period 2020 to 2028on August 3, 2021 at 4:55 am
The US Asthma & COPD Market for the forecasting period of 2019-2028. The report is made out with a comprehensive analysis of the current market and pulled down the key factors that propel the growth ...
- Researcher examining new link between obesity and asthmaon August 2, 2021 at 5:30 pm
An early-career scientist from The University of Western Australia who is analysing the connection between obesity and asthma was selected to present ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- You Can Blame Your Allergies on 'Botanical Sexism,' TikTokers Sayon August 2, 2021 at 12:40 pm
People on TikTok are pointing to botanical sexism as part of the reason why allergies seem to be getting worse.
- Reversing Obesity: Cytokine Treatment Causes Mice to Lose Weight by “Sweating” Faton July 31, 2021 at 12:42 am
A seemingly unremarkable observation — greasy hair — showed Penn researchers how the immune system could be targeted to reverse obesity Treating obese mice with the cytokine known as TSLP led to ...
- Household mould is making some Illawarra families sickon July 30, 2021 at 4:03 pm
"We originally thought it was her asthma, but the first question we got ... that you can't just go in an old building and put in a reverse cycle heater ... it will warm you but it will create ...
- Interior Department To Reverse Obama Rule Restricting Methane Emissionson July 30, 2021 at 4:52 am
Methane pollution also poses a risk to public health, especially to those who suffer from asthma or other breathing difficulties. The new rule comes after a federal judge rejected a bid by the ...
- Environmental racism: Youth Vs. Apocalypseon July 28, 2021 at 5:17 am
Besides a worsening climate, the pollutants are also linked to cancer, asthma, and birth defects ... run nonprofit that’s striving to not only reverse climate change, but the environmental ...